
ICU Medical (ICUI) Earnings Dates & Reports
ICU Medical (ICUI) Most Recent Earnings
Report DateMay 8, 2025
Period EndingQ1 2025
Est. EPS$1.28
Actual EPS$1.72
EarningsBeat
ICU Medical (ICUI) Earnings
View the latest ICU Medical (ICUI) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in ICU Medical (ICUI)
Order type
Buy in
Order amount
Est. shares
0 shares
ICU Medical (ICUI) Earnings per Share (EPS) History
Signup for full accessBrowse free
ICU Medical (ICUI) Latest Earnings
The value each ICUI share was expected to gain vs. the value each share gained.
ICU Medical (ICUI) reported its most recent earnings on May 8, 2025 for Q1 2025, posting earnings per share (EPS) of $1.72. This exceeded analysts' expectations of $1.28 by 34.37%, marking a Beat.
For comparison, ICU Medical reported EPS of $0.96 in the same quarter last year.
The company is expected to announce its next earnings report on 08/06/2025, with analysts projecting an EPS of $0.
ICU Medical (ICUI) Earnings History
ICU Medical (ICUI) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the ICU Medical’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 8, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 12, 2024 | — | — | — |
Aug 7, 2024 | — | — | — |
ICU Medical (ICUI) Earnings FAQs
ICU Medical (ICUI) last reported earnings on May 8, 2025 for Q1 2025, posting an EPS of $1.72, which Beat the estimate of $1.28 by 34.37%.
For Q1 2025, ICU Medical (ICUI) reported an EPS of $1.72, exceeding analysts' estimate of $1.28 by 34.37%.
For Q1 2025, ICU Medical (ICUI) Beat expectations with an actual EPS of $1.72 vs. an estimated EPS of $1.28.
Following the last earnings report on May 8, 2025, ICU Medical (ICUI)'s stock price moved — from — to —.
The next ICU Medical (ICUI) earnings call is scheduled for Aug. 6, 2025, where executives will discuss financial results and outlook.